AMR Clinical Knoxville is now enrolling adults ages 50 and older in an investigational pneumonia vaccine research study.
Qualified participants:
Are 50 to 64 and have never received a pneumonia vaccine OR
Are 65+ and have either never received a pneumonia vaccine or received a Pneumovax 23 vaccine more than 5 years ago.
Meet other study criteria .
Qualified participants will receive all study-related care and investigational vaccine at no cost. Compensation is available up to $362.50 for study-related time and travel.
If you're interested in learning more about this trial, you can reach out to AMR Clinical Knoxville today by calling 865-305-3784 or visiting their website at www.amr-clinical.com for more detailed information.
